home / stock / nvos / nvos news


NVOS News and Press, Novo Integrated Sciences Inc. From 05/31/24

Stock Information

Company Name: Novo Integrated Sciences Inc.
Stock Symbol: NVOS
Market: OTC
Website: novointegrated.com

Menu

NVOS NVOS Quote NVOS Short NVOS News NVOS Articles NVOS Message Board
Get NVOS Alerts

News, Short Squeeze, Breakout and More Instantly...

NVOS - US Companies Moving the Markets, Evening edition
Fri, May 31, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Novo Integrated Sciences Inc. (NVOS) rose 132.8% to $1.05 on volume of 308,155,573 shares Greenwave Technology Solutions Inc. (GWAV) fell 7.9% to $0.0387 on volume of 278,348,616 shares Faraday Future Intelligent Electric Inc. (FFIE) ...

NVOS - US Companies Moving the Markets, Morning edition
Fri, May 31, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 8.6% to $0.0384 on volume of 89,961,220 shares Nuburu Inc. (BURU) rose 29.4% to $0.207 on volume of 85,213,370 shares Novo Integrated Sciences Inc. (NVOS) rose 139.5% to $1.08 on volume ...

NVOS - Novo Integrated conducts strategic review to increase maximum amount under buyback program

2024-05-31 09:16:37 ET Novo Integrated Sciences ( NASDAQ: NVOS ) on Friday said its board is conducting a strategic review to determine whether it is appropriate to increase the maximum amount that can be repurchased under its stock buyback program. A potential repur...

NVOS - Novo Integrated Sciences' Board of Directors Conducting Strategic Review to Increase Maximum Amount under Stock Repurchase Program

As previously reported, the Board of Directors (the “Board”) of Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) approved the repurchase of up to $5 million of the Company’s outstanding common stock from time to time in the o...

NVOS - Novo Integrated Sciences Receives Confirmation of Ready, Willing and Able (RWA) Issued by HSBC for SBLC Leasing and Monetizing Program

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today that as part of a program to monetize a Standby Letter of Credit (“SBLC”), the Company has received written confirmation that a Ready, Willing and Able (“RWA&#x...

NVOS - Novo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M

2024-04-15 16:45:56 ET More on Novo Integrated Sciences Financial information for Novo Integrated Sciences Read the full article on Seeking Alpha For further details see: Novo Integrated Sciences GAAP EPS of -$0.16, revenue of $3.17M

NVOS - Novo Integrated Sciences Reports Fiscal Year 2024 Second Quarter Financial Results

Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation...

NVOS - Novo Integrated Sciences Closes on $6,210,000 Securities Purchase Agreement

Both the Mast Hill $3,500,000 Note and the FirstFire $277,777 Note were Paid in Full with Cash Proceeds from the Streeterville Note Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announced today the Company has entered into a securiti...

NVOS - Novo Integrated Sciences Subsidiary, Clinical Consultants International, Signs Agreement with Futura Surgicare Pvt Ltd.

Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), and Clinical Consultants International, LLC (“CCI”), a Novo wholly-owned subsidiary, today announced the signing of a Consulting Services Agreement (the “Agreement”), w...

NVOS - Novo Integrated Sciences Receives Limited Waiver to Securities Purchase Agreement for $70,000,000 Promissory Note

The Waiver Exempts any determination of non-compliance associated to Nasdaq’s Minimum Bid Price Requirement Rule Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”) announces today the Company has received a Limited Waiver, specific...

Previous 10 Next 10